NEW YORK, Dec. 18 (GenomeWeb News) - Tranzyme has acquired Québec-based Neokimia, the companies said today.
Financial details were not disclosed. However, Vipin Garg, president and CEO of Tranzyme, said both companies were valued at around $7.5 million at the time of the deal.
Registering provides access to this and other free content.
Already have an account?Login Now.
Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.
An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.
The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.
In Nature this week: genotypes linked to hip osteoarthritis, and more.